Evidence map›Paper›PMID 41214890›Full record

ReviewAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Multiscale Construction, Evaluation, and Application of Organoids.

Wanting Ma, Zhenglin Dong, Zhu'anzhen Zheng, Long Bai, Xingcai Zhang, Jiacan Su

Abstract readReview
In one paragraph

Review in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Highly Biomimetic Ectodermal Epithelial Organoids for Epithelial Barrier Stimulation Assays.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Multiscale Construction, Evaluation, and Application of Organoids.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wanting MaMedEng-X Institutes, Shanghai University, Shanghai, 200444, China.
Zhenglin DongDepartment of Orthopedics, Xinhua Hospital Affiliated to shanghai jiao Tong University school of Medicine, Shanghai, 200092, China.
Zhu'anzhen ZhengMedEng-X Institutes, Shanghai University, Shanghai, 200444, China.
Long BaiMedEng-X Institutes, Shanghai University, Shanghai, 200444, China.ORCID https://orcid.org/0000-0002-4757-746X
Xingcai ZhangWorld Tea Organization, Cambridge, MA, 02139, USA.ORCID https://orcid.org/0000-0001-7114-1095
Jiacan SuMedEng-X Institutes, Shanghai University, Shanghai, 200444, China.ORCID https://orcid.org/0000-0001-7080-263X

Funding

Key program of the National Natural Science Foundation of China 82230071National Natural Science Foundation of China 32471396National Natural Science Foundation of China 82172098National Natural Science Foundation of China 82230071Shanghai Clinical Research Plan SHDC2023CRT0l3Shanghai Committee of Science and Technology 23141900600Shanghai Municipal Demonstration Project for Innovative Medical Device Applications 23SHS05700Young Elite Scientist Sponsorship Program by China Association for Science and Technology YESS20230049
6 · The paper itself

Abstract

Organoids serve as pivotal models in both basic and applied research, offering transformative potential in biomedical applications. Herein is presented a comprehensive multi-scale perspective encompassing dual-scale construction, four-dimensional evaluation, triple-point application, and an analysis of the current challenges faced by organoid technology, aiming to advance organoid research and its biomedical applications. Dual-scale construction integrates micro-scale and macro-scale strategies to optimize material selection and spatial organization, thereby enhancing the biological fidelity of organoids. Four-dimensional evaluation systematically assesses functional performance and long-term stability at the molecular, cellular, organ, and in vivo levels, ensuring robust characterization. Triple-point application explores the translational potential of organoids in basic research, preclinical studies, and clinical applications, with a focus on disease modeling, drug screening, and regenerative medicine. By refining construction methodologies, improving evaluation frameworks and facilitating clinical translation, this multi-scale approach provides critical insights into optimizing organoid technology for biomedical research and therapeutic applications. The introduction of artificial intelligence (AI) empowers organoid research by enabling intelligent construction strategy screening, efficient multi-scale image analysis, rapid multi-omics data interpretation, and accurate preclinical assessment.

Indexed as

Biomedical ResearchOrganoidsAnimalsArtificial IntelligenceHumansRegenerative Medicineapplicationartificial intelligence (AI)evaluationmulti‐scale constructionorganoids

Identifiers

PMID41214890
PMCPMC12713053

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.